Results 151 to 160 of about 6,311,964 (280)

Precise algorithms for minimizing feedback in new energy product development. [PDF]

Sci Rep
Wang P, Ma G, Ma X, Huang W.
europepmc   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs. [PDF]

Pharmaceutics
Forbes B, Goodacre L, Lansley AB, Martin AR, Palmer H, Patterson C, Roe C, Scherließ R.   +7 more
europepmc   +1 more source

NEW PRODUCT DEVELOPMENT [PDF]

, 2013
Chuprina, A., Palehova, L.L.
core  

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Screening natural raw materials and product development for improving insomnia based on network pharmacology and data mining. [PDF]

Medicine (Baltimore)
Yue L, Jiao Q, Li J, Lu Y, Yi M, He C, Jia Y.   +6 more
europepmc   +1 more source

Rheology in Product Development: An Insight into 3D Printing of Hydrogels and Aerogels. [PDF]

Gels, 2023
Barrulas RV, Corvo MC.
europepmc   +1 more source

From Design to Production Control Through the Integration of Engineering Data Management and Workflow Management Systems

, 1997
At a time when many companies are under pressure to reduce "times-to-market" the management of product information from the early stages of design through assembly to manufacture and production has become increasingly important.
Baker, N., Bazan, A., Bityukov, S., Chevenier, G., Estrella, F., Flour, T. Le, Goff, J-M. Le, Kovacs, Z., Lieunard, S., McClatchey, R., Murray, S., Organtini, G., Vialle, J-P.   +12 more
core   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Applications of Artificial Intelligence in Biotech Drug Discovery and Product Development. [PDF]

MedComm (2020)
Liu YT, Zhang LL, Jiang ZY, Tian XS, Li PL, Wu PH, Du WT, Yuan BY, Xie C, Bu GL, Zhong LY, Yang YL, Li T, Zeng MS, Sun C.   +14 more
europepmc   +1 more source